1Katano M, Morisaki T. The past, the present and future of the OK-432 therapy for patients with malignant effusions[J].Anticancer Res,1998;18(5):3917-25.
2Nio Y, Nagami H, Tamura K,et al . Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone immunochemotherapy for malignant effusion [J].Br J Cancer,1999:(5-6):775-85.
